Showing 1 - 8 results of 8 for search 'Beata Sieklucka', query time: 0.04s Refine Results
  1. 1
    Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications

    Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications by Julia Nowowiejska, Anna Baran, Justyna Magdalena Hermanowicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Tumor Necrosis Factor (TNF) α, Endothelin (ET) 1 and α1-Acid Glycoprotein (AGP) as Potential Urine and Serum Markers of Metabolic Complications in Psoriasis?

    Tumor Necrosis Factor (TNF) α, Endothelin (ET) 1 and α1-Acid Glycoprotein (AGP) as Potential Urine and Serum Markers of Metabolic Complications in Psoriasis? by Julia Nowowiejska, Anna Baran, Justyna M. Hermanowicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Dose-dependent exposure to indoxyl sulfate alters AHR signaling, sirtuins gene expression, oxidative DNA damage, and bone mineral status in rats

    Dose-dependent exposure to indoxyl sulfate alters AHR signaling, sirtuins gene expression, oxidative DNA damage, and bone mineral status in rats by Malgorzata Karbowska, Krystyna Pawlak, Beata Sieklucka, Tomasz Domaniewski, Urszula Lebkowska, Radoslaw Zawadzki, Dariusz Pawlak

    Published 2024-01-01
    Get full text
    Article
  4. 4
    Gasdermin A (GSDMA) Tissue Expression, Serum and Urinary Concentrations With Clinicopathologic Outcome in Psoriasis

    Gasdermin A (GSDMA) Tissue Expression, Serum and Urinary Concentrations With Clinicopathologic Outcome in Psoriasis by Julia Nowowiejska, Anna Baran, Anna Pryczynicz, Justyna Hermanowicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak

    Published 2024-07-01
    Get full text
    Article
  5. 5
    Gasdermin B (GSDMB) in psoriatic patients–a preliminary comprehensive study on human serum, urine and skin

    Gasdermin B (GSDMB) in psoriatic patients–a preliminary comprehensive study on human serum, urine and skin by Julia Nowowiejska, Anna Baran, Anna Pryczynicz, Justyna Magdalena Hermanowicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak

    Published 2024-04-01
    Get full text
    Article
  6. 6
    Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer

    Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer by Justyna Magdalena Hermanowicz, Bartlomiej Kalaska, Krystyna Pawlak, Beata Sieklucka, Joanna Miklosz, Mariusz Mojzych, Dariusz Pawlak

    Published 2021-08-01
    Get full text
    Article
  7. 7
    Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue

    Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue by Julia Nowowiejska, Anna Baran, Anna Pryczynicz, Justyna Magdalena Hermanowicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak

    Published 2023-08-01
    Get full text
    Article
  8. 8
    Astrogliosis in an Experimental Model of Hypovitaminosis B12: A Cellular Basis of Neurological Disorders due to Cobalamin Deficiency

    Astrogliosis in an Experimental Model of Hypovitaminosis B12: A Cellular Basis of Neurological Disorders due to Cobalamin Deficiency by Zuzanna Rzepka, Jakub Rok, Justyna Kowalska, Klaudia Banach, Justyna Magdalena Hermanowicz, Artur Beberok, Beata Sieklucka, Dorota Gryko, Dorota Wrześniok

    Published 2020-10-01
    Get full text
    Article

Search Tools: